社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
蓝色鸢尾花
IP属地：海外
+关注
帖子 · 6
帖子 · 6
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
蓝色鸢尾花
蓝色鸢尾花
·
2021-02-02
狗咬狗一嘴毛，都不是好东西
非常抱歉，此主贴已删除
看
3,302
回复
评论
点赞
6
编组 21备份 2
分享
举报
蓝色鸢尾花
蓝色鸢尾花
·
2020-12-15
评论都在喊买16万股的兄弟回来看看🌝🌝🌝
看
2,496
回复
评论
点赞
1
编组 21备份 2
分享
举报
蓝色鸢尾花
蓝色鸢尾花
·
2020-12-15
美股一切皆有可能，一夜暴富😆😆😆😆
【妖股出现】单日暴涨2941%，震惊华尔街，代号 GLSI
@美股投资网：
格林威治生命科学公司(GLSI)今日股价飙升2,941%，24次熔断，日内交易者争相买入这家微型市值制药公司的股票。有1700多万股股票换手，是30天平均水平的700多倍。$Greenwich Lifesciences Inc(GLSI)$ 格林尼治首席执行长帕特尔(SnehalPatel)持有该公司65%的股份，当日收盘时该公司市值为6.86亿美元。这一切都源于格林威治生命科学公司在圣安东尼奥乳腺癌研讨会(SABCS)上发布的GP2期IIb临床试验五年数据，显示乳腺癌的复发率为0% 格林威治生命科学是一家临床生物制药公司，专注于GP2的研发。GP2是一种免疫疗法，用于预防曾接受过手术的患者的乳腺癌复发。迄今为止，138名接受GP2治疗的患者进行了4次临床试验，GP2治疗耐受性良好，没有观察到与GP2免疫治疗相关的严重不良事件。格林威治生命科学公司正计划开始III期临床试验，使用与IIb期临床试验类似的治疗方案。治疗类似人群的中度至重度(高风险T1,T2-T4)乳腺癌患者。 格林尼治首席执行长帕特尔(SnehalPatel)说:“大约80-85%的转移性乳腺癌患者不能存活。通过解决这一未被满足的需求，GP2可能达到一个超过50亿美元的潜在市场。”$特斯拉(TSLA)$
【妖股出现】单日暴涨2941%，震惊华尔街，代号 GLSI
看
2,926
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3568384999003717","uuid":"3568384999003717","gmtCreate":1605290975954,"gmtModify":1626751235417,"name":"蓝色鸢尾花","pinyin":"lsywhlanseyuanweihua","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5648b1e7e4835166493cde1f6833e3b7","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":28,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":315521242,"gmtCreate":1612265822186,"gmtModify":1703759516331,"author":{"id":"3568384999003717","authorId":"3568384999003717","name":"蓝色鸢尾花","avatar":"https://static.tigerbbs.com/5648b1e7e4835166493cde1f6833e3b7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568384999003717","authorIdStr":"3568384999003717"},"themes":[],"htmlText":"狗咬狗一嘴毛，都不是好东西","listText":"狗咬狗一嘴毛，都不是好东西","text":"狗咬狗一嘴毛，都不是好东西","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/315521242","repostId":"1198631699","repostType":4,"isVote":1,"tweetType":1,"viewCount":3302,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":394154390,"gmtCreate":1607965063010,"gmtModify":1703850413641,"author":{"id":"3568384999003717","authorId":"3568384999003717","name":"蓝色鸢尾花","avatar":"https://static.tigerbbs.com/5648b1e7e4835166493cde1f6833e3b7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568384999003717","authorIdStr":"3568384999003717"},"themes":[],"htmlText":"评论都在喊买16万股的兄弟回来看看🌝🌝🌝","listText":"评论都在喊买16万股的兄弟回来看看🌝🌝🌝","text":"评论都在喊买16万股的兄弟回来看看🌝🌝🌝","images":[{"img":"https://static.tigerbbs.com/0d7d6b42402ac962137c419d3b0cff10","width":"1080","height":"2160"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/394154390","isVote":1,"tweetType":1,"viewCount":2496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},{"id":394156640,"gmtCreate":1607964335580,"gmtModify":1703850409462,"author":{"id":"3568384999003717","authorId":"3568384999003717","name":"蓝色鸢尾花","avatar":"https://static.tigerbbs.com/5648b1e7e4835166493cde1f6833e3b7","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568384999003717","authorIdStr":"3568384999003717"},"themes":[],"htmlText":"美股一切皆有可能，一夜暴富😆😆😆😆","listText":"美股一切皆有可能，一夜暴富😆😆😆😆","text":"美股一切皆有可能，一夜暴富😆😆😆😆","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/394156640","repostId":"395950273","repostType":1,"repost":{"id":395950273,"gmtCreate":1607568662692,"gmtModify":1703848750251,"author":{"id":"3478213283465426","authorId":"3478213283465426","name":"美股投资网","avatar":"https://static.tigerbbs.com/a1bfd2cf1aa240d7058795c83d419510","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478213283465426","authorIdStr":"3478213283465426"},"themes":[],"title":"【妖股出现】单日暴涨2941%，震惊华尔街，代号 GLSI","htmlText":" 格林威治生命科学公司(GLSI)今日股价飙升2,941%，24次熔断，日内交易者争相买入这家微型市值制药公司的股票。有1700多万股股票换手，是30天平均水平的700多倍。<a target=\"_blank\" href=\"https://laohu8.com/S/GLSI\">$Greenwich Lifesciences Inc(GLSI)$</a> 格林尼治首席执行长帕特尔(SnehalPatel)持有该公司65%的股份，当日收盘时该公司市值为6.86亿美元。这一切都源于格林威治生命科学公司在圣安东尼奥乳腺癌研讨会(SABCS)上发布的GP2期IIb临床试验五年数据，显示乳腺癌的复发率为0% 格林威治生命科学是一家临床生物制药公司，专注于GP2的研发。GP2是一种免疫疗法，用于预防曾接受过手术的患者的乳腺癌复发。迄今为止，138名接受GP2治疗的患者进行了4次临床试验，GP2治疗耐受性良好，没有观察到与GP2免疫治疗相关的严重不良事件。格林威治生命科学公司正计划开始III期临床试验，使用与IIb期临床试验类似的治疗方案。治疗类似人群的中度至重度(高风险T1,T2-T4)乳腺癌患者。 格林尼治首席执行长帕特尔(SnehalPatel)说:“大约80-85%的转移性乳腺癌患者不能存活。通过解决这一未被满足的需求，GP2可能达到一个超过50亿美元的潜在市场。”<a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> ","listText":" 格林威治生命科学公司(GLSI)今日股价飙升2,941%，24次熔断，日内交易者争相买入这家微型市值制药公司的股票。有1700多万股股票换手，是30天平均水平的700多倍。<a target=\"_blank\" href=\"https://laohu8.com/S/GLSI\">$Greenwich Lifesciences Inc(GLSI)$</a> 格林尼治首席执行长帕特尔(SnehalPatel)持有该公司65%的股份，当日收盘时该公司市值为6.86亿美元。这一切都源于格林威治生命科学公司在圣安东尼奥乳腺癌研讨会(SABCS)上发布的GP2期IIb临床试验五年数据，显示乳腺癌的复发率为0% 格林威治生命科学是一家临床生物制药公司，专注于GP2的研发。GP2是一种免疫疗法，用于预防曾接受过手术的患者的乳腺癌复发。迄今为止，138名接受GP2治疗的患者进行了4次临床试验，GP2治疗耐受性良好，没有观察到与GP2免疫治疗相关的严重不良事件。格林威治生命科学公司正计划开始III期临床试验，使用与IIb期临床试验类似的治疗方案。治疗类似人群的中度至重度(高风险T1,T2-T4)乳腺癌患者。 格林尼治首席执行长帕特尔(SnehalPatel)说:“大约80-85%的转移性乳腺癌患者不能存活。通过解决这一未被满足的需求，GP2可能达到一个超过50亿美元的潜在市场。”<a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> ","text":"格林威治生命科学公司(GLSI)今日股价飙升2,941%，24次熔断，日内交易者争相买入这家微型市值制药公司的股票。有1700多万股股票换手，是30天平均水平的700多倍。$Greenwich Lifesciences Inc(GLSI)$ 格林尼治首席执行长帕特尔(SnehalPatel)持有该公司65%的股份，当日收盘时该公司市值为6.86亿美元。这一切都源于格林威治生命科学公司在圣安东尼奥乳腺癌研讨会(SABCS)上发布的GP2期IIb临床试验五年数据，显示乳腺癌的复发率为0% 格林威治生命科学是一家临床生物制药公司，专注于GP2的研发。GP2是一种免疫疗法，用于预防曾接受过手术的患者的乳腺癌复发。迄今为止，138名接受GP2治疗的患者进行了4次临床试验，GP2治疗耐受性良好，没有观察到与GP2免疫治疗相关的严重不良事件。格林威治生命科学公司正计划开始III期临床试验，使用与IIb期临床试验类似的治疗方案。治疗类似人群的中度至重度(高风险T1,T2-T4)乳腺癌患者。 格林尼治首席执行长帕特尔(SnehalPatel)说:“大约80-85%的转移性乳腺癌患者不能存活。通过解决这一未被满足的需求，GP2可能达到一个超过50亿美元的潜在市场。”$特斯拉(TSLA)$","images":[{"img":"https://static.tigerbbs.com/590bcce9c34193a05ef63ba1c7cb8163","width":"996","height":"622"},{"img":"https://static.tigerbbs.com/4e2c44ef247e1bb398b94cf93b54da5a","width":"600","height":"669"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/395950273","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2926,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}